Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone implant versus oral naltrexone for heroin dependence
ACTRN12606000308594Phase 2Completed
- Sponsor
- The University of Western Australia
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in heroin addiction (2 arms), sponsored by The University of Western Australia. Primary endpoints: Proportion with blood naltrexone concentrations above therapeutic levels and Accidental opiate overdose. Started Jan 2006; status: completed.
02
Drugs
naltrexone
03
Conditions
heroin addiction
Beyond the preview
Go deeper on ACTRN12606000308594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000308594.